Himalaya aiming at a 12% revenue growth in FY15
The company expects it's top line to touch a level of Rs 1,450 crore by the end of this fiscal.
New Delhi, September 25, 2014: The herbal wellness firm, Himalaya Drug Company is expecting a growth of over 12 per cent in its revenue to touch the Rs 1,450 crore level in the current fiscal on the back of robust sales in the domestic market.
The company posted revenue of Rs 1,300 crore in the previous fiscal and is eyeing a robust growth in 2014-15. The company is constantly exploring new routes to penetrate our brand across neew categories, existing markets, new markets and multiple demographics.
The company is following an organic route for expansion and is undertaking research and development activities to develop new drugs.
Around 38 per cent of the current revenue of the company comes from pharmaceuticals while the remaining is from baby care and animal health segments. Around 12 per cent revenue for the company comes from its exports across the world.